Recombinant Human DnaJ homolog subfamily B member 14 (DNAJB14) is a protein that belongs to the DnaJ family of molecular chaperones. These proteins are crucial for maintaining protein homeostasis within cells by facilitating protein folding, preventing protein aggregation, and promoting the degradation of misfolded proteins through the endoplasmic reticulum-associated degradation (ERAD) pathway .
DNAJB14 acts as a co-chaperone with HSPA8/Hsc70, enhancing its ATPase and polypeptide-binding activities. This interaction is essential for promoting protein folding and trafficking, as well as preventing the aggregation of client proteins . Additionally, DNAJB14 can function independently of Hsc70, particularly in conjunction with DNAJB12, to stabilize and assemble nascent potassium channel subunits into tetramers .
Protein Folding and Trafficking: DNAJB14 assists in the proper folding and transport of proteins.
Prevention of Protein Aggregation: It helps prevent the accumulation of misfolded proteins.
ERAD Pathway: Facilitates the degradation of improperly folded proteins through the ERAD pathway.
Potassium Channel Assembly: Collaborates with DNAJB12 to stabilize and assemble potassium channels.
Recent studies have highlighted the role of DNAJB14 in various cellular processes and diseases:
Mutant FUS Aggregation Protection: DNAJB14, particularly its full-length isoform, has been shown to protect against mutant FUS protein aggregation, which is associated with certain neurodegenerative diseases like amyotrophic lateral sclerosis (ALS) .
Antioxidant Ability: In certain organisms, such as A. cerana cerana, silencing DNAJB14 can lead to increased oxidative damage and decreased antioxidant capacity .
Viral Infection: DNAJB14 and DNAJB12 are essential for the infection process of simian virus 40 (SV40), as they facilitate the exit of viral capsids from the ER .
| Feature | DNAJB14-FL | DNAJB14-Short |
|---|---|---|
| J-Domain | Present | Absent |
| HSP70 Interaction | Yes | No |
| Aggregation Protection | Effective | Ineffective |
| Function | Description |
|---|---|
| Protein Folding | Assists in proper protein folding |
| Protein Trafficking | Facilitates protein transport |
| Aggregation Prevention | Prevents accumulation of misfolded proteins |
| ERAD Pathway | Promotes degradation of misfolded proteins |
| Potassium Channel Assembly | Stabilizes and assembles potassium channels |
| Feature | DNAJB14-FL | DNAJB14-Short |
|---|---|---|
| J-Domain | Present | Absent |
| HSP70 Interaction | Yes | No |
| Aggregation Protection | Effective | Ineffective |
DNAJB14 functions as a co-chaperone with HSPA8/Hsc70, essential for protein folding, trafficking, preventing aggregation of client proteins, and directing misfolded proteins to the endoplasmic reticulum-associated degradation (ERAD) pathway. Its mechanism involves modulating HSPA8/Hsc70's ATPase and polypeptide-binding activities. Independently of HSPA8/Hsc70, DNAJB14, in conjunction with DNAJB12, acts as a chaperone facilitating the maturation of potassium channels KCND2 and KCNH2 by stabilizing nascent channel subunits and assembling them into tetramers. While HSPA8/Hsc70 is crucial for stabilizing nascent channel proteins, the oligomerization of channel subunits proceeds independently of HSPA8/Hsc70. Overexpression leads to the formation of membranous structures (DJANGOs) with DNAJB12 and HSPA8/Hsc70 within the nucleus; the function of these structures remains unclear. In the context of polyomavirus infection, DNAJB14 is implicated in viral endoplasmic reticulum membrane penetration and subsequent infection.
Human DNAJB14 is an ER-located type II transmembrane protein characterized by a cytosolic N-terminal J-domain containing the conserved HPD motif essential for Hsc70 interaction, a glycine/phenylalanine-rich region, and a single transmembrane domain. The J-domain faces the cytosol while the C-terminus resides in the ER lumen, as confirmed by proteinase K protection assays . The protein runs at approximately 42-kDa on immunoblots and shares approximately 50% sequence identity with its close family member DNAJB12 . The full-length protein consists of 379 amino acids with the J-domain positioned within the first 250 amino acids of the N-terminal region .
To study DNAJB14's topology, researchers typically employ approaches such as:
Immunofluorescence microscopy to confirm ER localization
Proteinase K protection assays using purified microsomes to determine membrane orientation
Recombinant expression with specific tags for antibody detection
Comparative sequence alignment with other DnaJ family members to identify conserved domains
DNAJB14 primarily functions as a co-chaperone that regulates HSPA8/Hsc70's ATPase and polypeptide-binding activities, which are crucial for protein quality control mechanisms . This interaction facilitates the recognition and processing of misfolded proteins, particularly membrane proteins destined for degradation via the endoplasmic reticulum-associated degradation (ERAD) pathway . Experimental evidence demonstrates that DNAJB14 specifically enhances the degradation of misfolded membrane proteins such as CFTRΔF508 (the mutant cystic fibrosis transmembrane conductance regulator), but not misfolded ER luminal proteins like the null-Hong Kong variant of α1-antitrypsin (A1AT-NHK) .
DNAJB14 can also function independently of HSPA8/Hsc70 in certain contexts. For instance, it collaborates with DNAJB12 to promote the maturation of potassium channels like KCND2 and KCNH2 by stabilizing nascent channel subunits and facilitating their assembly into tetramers . While the stabilization of nascent channel proteins depends on HSPA8/Hsc70, the oligomerization process can proceed independently of this chaperone . This dual functionality highlights DNAJB14's versatility in protein quality control mechanisms.
Unlike DNAJB12, which shows broad expression across multiple tissues, DNAJB14 exhibits a more restricted expression pattern with particularly prominent expression in testis . RT-PCR analysis has shown that DNAJB14 mRNA is expressed at relatively lower levels compared to DNAJB12 in most tissues, suggesting potential tissue-specific functions . This differential expression pattern implies that these two analogous proteins may have evolved separately to perform distinct functions despite their structural similarities .
For detecting DNAJB14 in research settings, several complementary approaches can be employed:
Antibody-based detection:
Immunohistochemistry (IHC-P): Commercially available antibodies like ab238729 have been validated for paraffin-embedded tissues, with optimal dilutions around 1/100 .
Immunocytochemistry/Immunofluorescence (ICC/IF): The same antibodies can be used with cultured cells at similar dilutions (1/100), typically with Alexa Fluor-conjugated secondary antibodies .
Western blotting: Anti-DNAJB14 antibodies targeting either the N-terminus or C-terminus can detect the full-length 42-kDa protein. Region-specific antibodies are particularly useful for topology studies .
mRNA detection:
RT-PCR with gene-specific primers can quantify DNAJB14 expression across tissues, with β-actin often used as a normalization control .
For cloning the coding sequences (CDSs) of DNAJB14, specific primers can be designed based on reference sequences available in databases like NCBI (Gene ID: 107994739 for A. cerana) .
To generate recombinant DNAJB14, researchers typically clone the full coding sequence into appropriate expression vectors, with immunogen fragments frequently corresponding to amino acids 1-250 of the human protein . For functional studies, it's important to verify proper ER localization and topology of the recombinant protein through colocalization with ER markers and membrane fractionation.
To investigate DNAJB14's function in protein degradation pathways, researchers can employ several methodological approaches:
Cycloheximide chase experiments:
Transfect cells with a model substrate (e.g., CFTRΔF508) along with DNAJB14 or control vectors
Treat cells with cycloheximide to block new protein synthesis
Collect samples at different time points (0, 2, 4, 6 hours)
Analyze protein levels by immunoblotting
Quantify protein degradation rates through densitometric analysis
Genetic manipulation approaches:
Overexpression studies to assess gain-of-function effects on substrate degradation
siRNA-mediated knockdown or CRISPR-Cas9 knockout of DNAJB14 to evaluate loss-of-function effects
Rescue experiments with wild-type or mutant versions of DNAJB14 (particularly J-domain mutants like H/Q mutations in the HPD motif)
Proteasome inhibition studies:
Treatment with proteasome inhibitors like MG132 to determine if DNAJB14-mediated degradation requires proteasomal function
Analysis of ubiquitination status of substrate proteins in the presence or absence of DNAJB14
When designing such experiments, it's crucial to include appropriate model substrates. CFTRΔF508 is widely used as a model for ER membrane proteins, while A1AT-NHK serves as a control for ER luminal proteins . These complementary approaches can provide comprehensive insights into DNAJB14's specific role in the ERAD pathway.
DNAJB14 exhibits distinctive responses to various cellular stressors, providing insights into its physiological functions:
Mitochondrial stress response:
DNAJB14 shows a notable response to mitochondrial stress induced by CCCP (carbonyl cyanide m-chlorophenyl hydrazone), a mitochondrial potential uncoupler . This regulation indicates a potential role in inter-organelle communication between the ER and mitochondria, particularly in stress conditions.
Heat stress response:
Unlike classical heat shock proteins, DNAJB14 expression does not appear to be significantly upregulated by heat stress in experimental settings . When NIH3T3 cells were incubated at 42°C, researchers did not observe substantial changes in DNAJB14 mRNA levels , distinguishing it from canonical heat-inducible chaperones.
This differential stress responsiveness suggests that DNAJB14 may have evolved specialized functions distinct from general stress-inducible chaperones, potentially explaining why its tissue distribution differs from the more ubiquitous DNAJB12.
Recent research has uncovered an unexpected role for DNAJB14 in mitochondrial dynamics:
Mitochondrial morphology alterations:
Cells depleted of DNAJB14 exhibit increased mitochondrial count and branching . This phenotype suggests DNAJB14 may directly or indirectly influence mitochondrial fission/fusion processes under both normal and stress conditions.
PINK1 stabilization regulation:
DNAJB14 knockout (KO) cells show prolonged stabilization of PTEN-induced kinase 1 (PINK1) during chronic exposure to CCCP . Additionally, DNAJB14 overexpression can affect PINK1 expression levels under CCCP-mediated stress . PINK1 is a critical regulator of mitochondrial quality control and mitophagy, suggesting DNAJB14 may influence these processes.
Drp1 phosphorylation kinetics:
Cells with genetic knockout of DNAJB14 display altered kinetics of phosphorylated Drp1 in response to CCCP treatment . As Drp1 is a key mediator of mitochondrial fission, this observation further supports DNAJB14's involvement in mitochondrial dynamics regulation.
These findings represent a novel facet of DNAJB14 function and highlight the emerging concept of ER-mitochondria communication in cellular homeostasis. Further research is needed to elucidate the precise molecular mechanisms through which this ER-resident protein influences mitochondrial processes.
| DNAJB14 Manipulation | Effect on Mitochondria | Effect on PINK1 | Effect on Drp1 |
|---|---|---|---|
| Knockout | Increased mitochondrial count and branching | Prolonged stabilization during CCCP exposure | Altered phosphorylation kinetics |
| Overexpression | Not fully characterized | Affected expression levels under CCCP stress | Not fully characterized |
Distinguishing between the functions of these highly similar proteins presents a significant challenge in research. Strategic approaches include:
Comparative expression analysis:
Leverage the differential tissue expression patterns, with DNAJB14 showing higher expression in testis while DNAJB12 is more broadly expressed . This natural variation provides an opportunity to study tissue-specific roles.
Domain-specific mutations:
Generate chimeric proteins by swapping domains between DNAJB14 and DNAJB12 to identify which regions confer functional specificity. Key domains to consider include the J-domain, the transmembrane domain, and the C-terminal region.
Substrate specificity profiling:
While both proteins promote the degradation of misfolded membrane proteins, they might exhibit preferences for different substrates. Comprehensive profiling using proteomics approaches can reveal unique client proteins for each chaperone.
Interactome analysis:
Identify protein-protein interaction networks using techniques like immunoprecipitation followed by mass spectrometry. This can reveal differential binding partners that might explain unique functions.
Double knockout studies:
Generate single and double knockout cell lines of DNAJB14 and DNAJB12 to assess compensatory mechanisms and identify functions that require both proteins versus those that are specific to each.
Despite their structural similarities, evolutionary analysis suggests these proteins have evolved separately to perform distinct functions . Their differential expression patterns and potentially specialized roles in different cellular contexts make them an interesting model system for studying the diversification of chaperone functions.
When investigating DNAJB14 in disease contexts, researchers should consider several methodological approaches and challenges:
Neurodegeneration models:
Given that ER homeostasis disruption can lead to neurodegeneration , DNAJB14's role in protein quality control makes it a candidate factor in neurodegenerative diseases. Consider:
Analyzing DNAJB14 expression and function in cellular and animal models of protein misfolding diseases
Evaluating the effects of DNAJB14 modulation on the accumulation of disease-associated misfolded proteins
Investigating potential genetic associations between DNAJB14 variants and neurodegeneration risk
Cancer research applications:
DNAJB14 has been detected in liver cancer tissue and HeLa cells (cervical adenocarcinoma) , suggesting potential roles in cancer biology:
Assess DNAJB14 expression across cancer types and correlate with clinical outcomes
Investigate how DNAJB14-mediated protein quality control affects oncogenic signaling pathways
Explore whether DNAJB14's involvement in mitochondrial dynamics influences cancer cell metabolism
Viral infection studies:
DNAJB14 has been implicated in polyomavirus endoplasmic reticulum membrane penetration and infection :
Develop assays to measure viral penetration efficiency in the presence or absence of DNAJB14
Investigate potential interactions between viral proteins and DNAJB14
Assess whether DNAJB14 expression is modulated during viral infection
Technical considerations:
When working with disease models, carefully control for confounding factors that might affect ER and mitochondrial stress responses
Consider tissue-specific differences in DNAJB14 expression when selecting appropriate disease models
Account for potential compensatory mechanisms, particularly from DNAJB12, when interpreting results from DNAJB14 knockout or knockdown experiments
The current understanding of DNAJB14 points to several promising avenues for future research:
Mechanistic studies of ER-mitochondria communication:
The unexpected finding that DNAJB14 influences mitochondrial dynamics opens up new research directions exploring how this ER-resident protein mediates inter-organelle signaling. Future studies should investigate the molecular mechanisms through which DNAJB14 affects PINK1 stabilization and Drp1 phosphorylation, potentially identifying new pathways of ER-mitochondria communication.
Tissue-specific functions:
Given DNAJB14's enriched expression in testis compared to other tissues, investigating its potential specialized roles in this tissue could reveal novel functions. This might include studying spermatogenesis, sperm maturation, or other testis-specific cellular processes where protein quality control is crucial.
Therapeutic potential:
Understanding DNAJB14's role in protein quality control and stress responses could lead to therapeutic applications. For diseases involving protein misfolding or dysregulated mitochondrial dynamics, modulating DNAJB14 activity might provide a novel intervention strategy. This would require developing methods to specifically enhance or inhibit DNAJB14 function in relevant disease contexts.
Evolution of J-protein specialization: Comparative studies between DNAJB14 and DNAJB12 across species could provide insights into how J-proteins evolve specialized functions. The observation that these highly similar proteins have distinct expression patterns suggests evolutionary pressure for functional diversification, providing an interesting model for studying chaperone evolution.